An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

BACKGROUND: Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbam...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS Negl Trop Dis
Main Authors: Jambulingam, Purushothaman, Kuttiatt, Vijesh Sreedhar, Krishnamoorthy, Kaliannagounder, Subramanian, Swaminathan, Srividya, Adinarayanan, Raju, Hari Kishan K., Rahi, Manju, Somani, Roopali K., Suryaprakash, Mallanna K., Dwivedi, Gangeshwar P., Weil, Gary J.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7909694/
https://ncbi.nlm.nih.gov/pubmed/33591979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009069
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki